Delivery Order SPE2DB22D2211-SPE2DB23FPEV0
Award Date
9/18/23
Potential Completion Date
9/19/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Olopatadine HCL 0.1% eye drops in 5 mL containers. The fixed-price, firm-fixed delivery order contract has an ultimate completion date of March 2, 2023 and a ceiling value of $2,777.51. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,274.40 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,558,202,540 units of Olopatadine HCL 0.1% eye drops in 5 milliliter vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, for the provision of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $1,297.14 delivery order is a firm-fixed price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Olopatadine HCL 0.1% eye drops to the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,575.68 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
The federal contract award is for the delivery of Olopatadine HCL 0.1% eye drops, 5 mL, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $1,723.35 and is a firm fixed-price delivery order contract. There is no set-aside designation mentioned in the award details. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of Olopatadine HCl 0.1% Eye Drops in 5 mL bottles. The $4,249.70 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD), and has a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order from the Defense Logistics Agency (DLA) for $2,987.69 to supply Olopatadine HCl 0.1% eye drops. The award has an ultimate completion date of January 14, 2025 and is a Firm Fixed Price contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,973.38 firm-fixed-price delivery order is for the supply of Olopatadine Hydrochloride 0.1% Eye Drops in 5-milliliter quantities. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen...
The federal contract award summarizes a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The $6,233.63 firm-fixed-price contract was awarded by the Defense Logistics Agency and has a completion date of November 29, 2023. The contract is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the Defense Logistics Agency...
This federal contract award is a delivery order valued at $8,827.19 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olopatadine 0.1% OS, a prescription eye drop medication. This award is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a wide range of pharmaceutical and medical...